BONE MARROW RETICULIN FIBROSIS AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED IN THE ERA OF NOVEL AGENTS

被引：0
|
作者：
Suriu, C. [1 ,2 ]
Livne, M. [2 ]
Sonkin, V. [1 ]
Akria, L. [1 ,2 ]
Barhoum, M. [1 ]
Braester, A. [1 ,2 ]
机构：
[1] Galilee Med Ctr, Nahariyya, Israel
[2] Bar Ilan Univ, Fac Med Galilee, Safed, Israel
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1976
引用
收藏
页码：793 / 793
页数：1
相关论文
共 50 条
  • [1] Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
    Kim, Dae Sik
    Yu, Eun Sang
    Kang, Ka-Won
    Lee, Se Ryeon
    Park, Yong
    Sung, Hwa Jung
    Choi, Chul Won
    Kim, Byung Soo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (04): : 711 - 721
  • [2] The presence of bone marrow fibrosis is associated with poorer prognosis in newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.
    Paul, Barry
    Loitsch, Gavin
    Feinberg, Daniel
    Barak, Ian
    Li, Zhiguo
    Wang, Endi
    Zhao, Yue
    Dupuis, Megan
    Kang, Yubin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents
    Nathwani, Nitya
    Larsen, Jeremy T.
    Kapoor, Prashant
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (02) : 127 - 136
  • [4] Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents
    Nitya Nathwani
    Jeremy T. Larsen
    Prashant Kapoor
    Current Hematologic Malignancy Reports, 2016, 11 : 127 - 136
  • [5] The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors
    Paul, Barry
    Zhao, Yue
    Loitsch, Gavin
    Feinberg, Daniel
    Mathews, Parker
    Barak, Ian
    Dupuis, Megan
    Li, Zhiguo
    Rein, Lindsay
    Wang, Endi
    Kang, Yubin
    CANCER MEDICINE, 2020, 9 (16): : 5869 - 5880
  • [6] Relationship Between Serum Periostin Level and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma Patients
    Tuna, Ali Kursat
    Tekinalp, Atakan
    Kilinc, Ibrahim
    Demircioglu, Sinan
    Kaya, Bahattin Engin
    Ceneli, Ozcan
    Kilinc, Fahriye
    NAMIK KEMAL MEDICAL JOURNAL, 2023, 11 (02): : 158 - 162
  • [7] Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors
    Hu, Xiumei
    Dai, Xiangyang
    Guo, Xinmeng
    Jiang, Xingran
    Li, Yunlong
    Zhao, Hongying
    Lu, Jun
    Li, Xue
    Jin, Mulan
    DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [8] Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients
    Suriu, C.
    Akria, L.
    Azoulay, D.
    Shaoul, E.
    Barhoum, M.
    Braester, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (03) : e56 - e59
  • [9] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Egerer, G.
    Hose, D.
    Sauer, S.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ONKOLOGIE, 2013, 36 : 152 - 152
  • [10] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Sauer, S.
    Egerer, G.
    Hundemer, M.
    Hose, D.
    Kunz, C.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 189 - 195
12345